4.7 Article

Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Platelet aggregation is not altered among men with diabetes mellitus

Christian Kring et al.

ACTA DIABETOLOGICA (2020)

Article Cardiac & Cardiovascular Systems

Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts

Benjamin A. T. Rodriguez et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Article Medicine, General & Internal

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

S. D. Wiviott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice

Annas Al-Sharea et al.

ATHEROSCLEROSIS (2018)

Review Cardiac & Cardiovascular Systems

A Central Role for Monocyte-Platelet Interactions in Heart Failure

Nadezhda Glezeva et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)

Review Endocrinology & Metabolism

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis

Alice Ossoli et al.

ENDOCRINOLOGY AND METABOLISM (2016)

Article Medicine, General & Internal

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

An accelerated mouse model for atherosclerosis and adipose tissue inflammation

Angelika Neuhofer et al.

CARDIOVASCULAR DIABETOLOGY (2014)

Article Cell Biology

Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis

Prabhakara R. Nagareddy et al.

CELL METABOLISM (2013)

Article Medicine, General & Internal

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial

R. R. Henry et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)

Review Medicine, General & Internal

A Tale of Coronary Artery Disease and Myocardial Infarction

Elizabeth G. Nabel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medical Laboratory Technology

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Robert S. Rosenson et al.

CLINICAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Matthew J. Butcher et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)

Article Cardiac & Cardiovascular Systems

Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis

Nadine Nagy et al.

BASIC RESEARCH IN CARDIOLOGY (2010)

Review Pharmacology & Pharmacy

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

Laura Calabresi et al.

CURRENT PHARMACEUTICAL DESIGN (2010)

Article Pharmacology & Pharmacy

Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects

B. Komoroski et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

Article Medicine, General & Internal

Effects of intensive glucose lowering in type 2 diabetes

Hertzel C. Gerstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Hematology

Development of a calibrated automated thrombography based thrombin generation test in mouse plasma

S. N. Tchaikovski et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Review Cardiac & Cardiovascular Systems

Endothelial and antithrombotic actions of HDL

Chieko Mineo et al.

CIRCULATION RESEARCH (2006)

Article Medicine, General & Internal

Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes

N Eibl et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Biochemistry & Molecular Biology

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E

YQ Huo et al.

NATURE MEDICINE (2003)

Article Endocrinology & Metabolism

LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice

SA Schreyer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)